IPO YEAR:
|
Sector:
Health Care
|
Industry:
Biotechnology: Biological Products (No Diagnostic Substances)
|
ADRTSO:
|
MarketCap:
9942914328.00
|
Beta:
|
52 Week High:
113.81
|
52 Week Low:
68
|
52 Week Change:
-0.2469508439078477
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
157275200
|
Dividend Rate:
0.31928790821068315
|
Dividend Yield:
1.42%
|
ExDividend Date:
2023-02-10
|
Latest EPS:
|
Latest EPS Date:
3 May 2023
|
Float:
0
|
return on Equity:
15.00%
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
$399.805M
|
ttmEPS:
1.61
|
Revenue:
$1.120B
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
97.90%
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
0.80%
|
Return on Assets:
11.20%
|
Return on Capital:
|
Profit Margin:
23.40%
|
Price to Sales:
10.52
|
Price To Book:
6.25
|
Short Ratio:
|
PE Ratio:
47.01382938533484
|
Employees:
3000
|
1Y Guesstimate
177.508:2.0:4
|
|
|
|
|
|
|
|
|
